🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Oto Smartphone App in Treating Tinnitus Amongst Adult Patients Compared with Standard Talking Therapies

RecruitingPhase 3Ages 18 Years - anyAllEast and North Hertfordshire NHS Trust
NCT06623123 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A study that looks at treating tinnitus and its associated burden, insomnia and quality of life effects with a smartphone app when compared with the talking therapies already offered on the national health service. Three separate questionnaires will be used to collect this data from patients at regular time intervals.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients (male or female) aged over 18 years of age presenting to NHS ENT and hearing services with primary non-pulsatile tinnitus irrespective of hearing. * Patients must be suffering from tinnitus for a minimum of 3 months * Patients that have a willingness to use as well as have access to a smartphone device capable of running Oto. * Willing and able to provide written informed consent. * Those that would be offered tinnitus retraining therapy (TRT) as management for their primary tinnitus Exclusion Criteria: * Patients with secondary tinnitus as confirmed by magnetic resonance imaging (MRI). * Patients undergoing any other tinnitus therapies concurrently (including hearing aids / implants). Previous tinnitus therapies including CBT in the past are accepted. * Patients who are not willing to use the app due to not having a suitable phone to download the application or due to own limitations in working Oto.
💊

What it tests

  • Oto Smartphone Application (Oto Health Ltd)
  • Tinnitus Retraining Therapy (TRT)
📍

Where

1 site
East and North Hertfordshire NHS Trust
Stevenage, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy